Christoph Mancao

3.1k total citations
42 papers, 1.2k citations indexed

About

Christoph Mancao is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Christoph Mancao has authored 42 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 14 papers in Cancer Research and 13 papers in Pathology and Forensic Medicine. Recurrent topics in Christoph Mancao's work include Colorectal Cancer Treatments and Studies (21 papers), Genetic factors in colorectal cancer (10 papers) and Cancer Treatment and Pharmacology (7 papers). Christoph Mancao is often cited by papers focused on Colorectal Cancer Treatments and Studies (21 papers), Genetic factors in colorectal cancer (10 papers) and Cancer Treatment and Pharmacology (7 papers). Christoph Mancao collaborates with scholars based in United States, Switzerland and Germany. Christoph Mancao's co-authors include Wolfgang Hammerschmidt, Priti S. Hegde, Jeffrey J. Wallin, Berit Jungnickel, Persis Amrolia, Martin Pulé, Sujith Samarasinghe, Helén Karlsson, Heinz‐Josef Lenz and Karin Straathof and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Christoph Mancao

39 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christoph Mancao United States 15 867 396 312 221 165 42 1.2k
Martin‐Leo Hansmann Germany 18 530 0.6× 819 2.1× 352 1.1× 182 0.8× 163 1.0× 27 1.3k
Hui‐Lan Rao China 20 664 0.8× 298 0.8× 222 0.7× 218 1.0× 259 1.6× 44 1.1k
Erik Yusko United States 16 984 1.1× 158 0.4× 710 2.3× 242 1.1× 167 1.0× 30 1.4k
Jessica Spahn United States 17 503 0.6× 150 0.4× 351 1.1× 260 1.2× 166 1.0× 27 1.1k
Bin Meng China 18 334 0.4× 151 0.4× 136 0.4× 186 0.8× 245 1.5× 62 814
Rosaria De Filippi Italy 19 467 0.5× 453 1.1× 386 1.2× 109 0.5× 307 1.9× 61 1.2k
Chit Chow Hong Kong 21 646 0.7× 184 0.5× 117 0.4× 568 2.6× 534 3.2× 53 1.4k
M-L Hansmann Germany 13 392 0.5× 493 1.2× 319 1.0× 63 0.3× 233 1.4× 23 907
Ferdinando Frigeri Italy 19 339 0.4× 437 1.1× 116 0.4× 83 0.4× 211 1.3× 60 1.2k
Keiichiro Honma Japan 14 471 0.5× 366 0.9× 283 0.9× 175 0.8× 283 1.7× 82 1.0k

Countries citing papers authored by Christoph Mancao

Since Specialization
Citations

This map shows the geographic impact of Christoph Mancao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Mancao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Mancao more than expected).

Fields of papers citing papers by Christoph Mancao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christoph Mancao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Mancao. The network helps show where Christoph Mancao may publish in the future.

Co-authorship network of co-authors of Christoph Mancao

This figure shows the co-authorship network connecting the top 25 collaborators of Christoph Mancao. A scholar is included among the top collaborators of Christoph Mancao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoph Mancao. Christoph Mancao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Battaglin, Francesca, Joshua Millstein, Sebastian Stintzing, et al.. (2023). Single nucleotide polymorphisms (SNPs) in MHC class I and II genes to predict outcome in patients (pts) with metastatic colorectal cancer (mCRC): Data from FIRE-3, MAVERICC, and TRIBE trials.. Journal of Clinical Oncology. 41(16_suppl). 3578–3578. 2 indexed citations
2.
Cannarile, Michael A., Vaios Karanikas, Bernhard Reis, et al.. (2023). Facts and Hopes on Biomarkers for Successful Early Clinical Immunotherapy Trials: Innovative Patient Enrichment Strategies. Clinical Cancer Research. 30(8). 1448–1456. 1 indexed citations
3.
4.
Millstein, Joshua, Francesca Battaglin, Hiroyuki Arai, et al.. (2022). fdrci: FDR confidence interval selection and adjustment for large-scale hypothesis testing. Bioinformatics Advances. 2(1). vbac047–vbac047. 4 indexed citations
5.
Loupakis, Fotios, Sebastian Stintzing, Hiroyuki Arai, et al.. (2022). Genetic variants involved in the cGAS-STING pathway predict outcome in patients with metastatic colorectal cancer: Data from FIRE-3 and TRIBE trials. European Journal of Cancer. 172. 22–30. 7 indexed citations
6.
Arai, Hiroyuki, Shu Cao, Francesca Battaglin, et al.. (2021). RNA-Binding Protein Polymorphisms as Novel Biomarkers to Predict Outcomes of Metastatic Colorectal Cancer: A Meta-analysis from TRIBE, FIRE-3, and MAVERICC. Molecular Cancer Therapeutics. 20(6). 1153–1160.
7.
Wang, Jingyuan, Joshua Millstein, Fotios Loupakis, et al.. (2021). Genetic variants involved in the lipid metabolism pathway to predict outcome in patients (pts) with metastatic colorectal cancer (mCRC): Data from FIRE-3 and MAVERICC trials.. Journal of Clinical Oncology. 39(3_suppl). 118–118. 1 indexed citations
8.
Max, Xiaoju, Johanna C. Bendell, Herbert I. Hurwitz, et al.. (2020). Disease Monitoring Using Post-induction Circulating Tumor DNA Analysis Following First-Line Therapy in Patients with Metastatic Colorectal Cancer. Clinical Cancer Research. 26(15). 4010–4017. 19 indexed citations
9.
Arai, Hiroyuki, Fotios Loupakis, Natsuko Kawanishi, et al.. (2020). Immunogenic cell death pathway polymorphisms for predicting oxaliplatin efficacy in metastatic colorectal cancer. Journal for ImmunoTherapy of Cancer. 8(2). e001714–e001714. 27 indexed citations
10.
Johnson, Radia Marie, Heidi Phillips, Carlos Bais, et al.. (2020). Development of a gene expression–based prognostic signature for IDH wild-type glioblastoma. Neuro-Oncology. 22(12). 1742–1756. 19 indexed citations
11.
Schmoll, Hans‐Joachim, Dirk Arnold, Aimery de Gramont, et al.. (2018). MODUL—a multicenter randomized clinical trial of biomarker-driven maintenance therapy following first-line standard induction treatment of metastatic colorectal cancer: an adaptable signal-seeking approach. Journal of Cancer Research and Clinical Oncology. 144(6). 1197–1204. 23 indexed citations
12.
Parikh, Aparna R., Fa-Chyi Lee, Linda Yau, et al.. (2018). MAVERICC, a Randomized, Biomarker-stratified, Phase II Study of mFOLFOX6-Bevacizumab versus FOLFIRI-Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer. Clinical Cancer Research. 25(10). 2988–2995. 39 indexed citations
13.
Pelt, Gabi W. van, Hans Gelderblom, Christoph Mancao, et al.. (2018). Predictive potential of tumour-stroma ratio on benefit from adjuvant bevacizumab in high-risk stage II and stage III colon cancer. British Journal of Cancer. 119(2). 164–169. 26 indexed citations
14.
15.
Hegde, Priti S., Jeffrey J. Wallin, & Christoph Mancao. (2017). Predictive markers of anti-VEGF and emerging role of angiogenesis inhibitors as immunotherapeutics. Seminars in Cancer Biology. 52(Pt 2). 117–124. 322 indexed citations
16.
Pelt, Gabi W. van, et al.. (2017). Predictive potential of tumour-stroma ratio on benefit from adjuvant bevacizumab in high-risk stage II and stage III colon cancer. Annals of Oncology. 28. v168–v169. 6 indexed citations
17.
18.
19.
Mancao, Christoph & Wolfgang Hammerschmidt. (2007). Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival. Blood. 110(10). 3715–3721. 182 indexed citations
20.
Mancao, Christoph, et al.. (2005). Rescue of “crippled” germinal center B cells from apoptosis by Epstein-Barr virus. Blood. 106(13). 4339–4344. 140 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin‐Leo Hansmann Breakdown of academic impact, for papers by Hui‐Lan Rao Breakdown of academic impact, for papers by Erik Yusko Breakdown of academic impact, for papers by Jessica Spahn Breakdown of academic impact, for papers by Bin Meng Breakdown of academic impact, for papers by Rosaria De Filippi Breakdown of academic impact, for papers by Chit Chow Breakdown of academic impact, for papers by M-L Hansmann Breakdown of academic impact, for papers by Ferdinando Frigeri Breakdown of academic impact, for papers by Keiichiro Honma
Rankless by CCL
2026